IMA Q2 2021 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+15.5% YoY

Gross Profit

-$8M-220.5% margin

Operating Income

-$13M-357.5% margin

Net Income

-$13M-357.3% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$279M

Total Liabilities

$63M

Stockholders' Equity

$216M

Cash & Equivalents

$264M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+15.5%
Gross Profit	-$8M	-$3M	-140.0%
Operating Income	-$13M	-$5M	-150.8%
Net Income	-$13M	-$5M	-151.7%